登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>TRBC1 >TR1-H52H4

Human TRBC1 Protein, His Tag

分子别名(Synonym)

T cell receptor beta constant 1,TRBC1

表达区间及表达系统(Source)

Human TRBC1, His Tag (TR1-H52H4) is expressed from human 293 cells (HEK293). It contains AA Asp 1 - Ala 144 (Accession # P01850-1).

Request for sequence

蛋白结构(Molecular Characterization)

Online(Asp 1 - Ala 144) P01850-1

This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 18.2 kDa. The protein migrates as 20 kDa and 24 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

内毒素(Endotoxin)

Less than 1.0 EU per μg by the LAL method.

纯度(Purity)

>90% as determined by SDS-PAGE.

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.
 

电泳(SDS-PAGE)

Human TRBC1, His Tag (Cat. No. TR1-H52H4) SDS-PAGE gel

Human TRBC1, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

背景(Background)

The transmembrane protein, TCR, comprise of two disulphide-linked polypeptide chains: a α and β chain, a γ and δ chain. Each polypeptide chain consists of a variable and a constant region. TRBC1 is the constant region of T-cell receptor (TCR) beta chain.

 

 

前沿进展

 
 
货号/价格
产品推荐
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
TRBC1靶点信息
英文全称:TRBC1
中文全称:人T细胞受体β-1链C区
种类:
上市药物数量:0详情
临床药物数量:5详情
最高研发阶段:临床二期
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定